Vimta Labs Ltd.
Snapshot View

429.40 -4.75 ▼-1.1%

06 December 2022, 04:01:00 PM
Volume: 1,754

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.vimta.com
Market Cap 952.94 Cr.
Enterprise Value(EV) 951.52 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 22.04 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 19.48 Trailing Twelve Months Ending 2022-09
Industry PE 50.25 Trailing Twelve Months Ending 2022-09
Book Value / Share 115.87 Trailing Twelve Months Ending 2022-09
Price to Book Value 3.71 Calculated using Price: 429.40
Dividend Yield 0.47 Period Ending 2022-03
No. of Shares Subscribed 2.21 Cr. 22,122,829 Shares
FaceValue 2
Company Profile
Vimta Labs is India's leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.09%
1 Week
-10.58%
1 Month
-6.74%
3 Month
+20.28%
6 Month
+28.45%
1 Year
+1.87%
2 Year
+168.12%
5 Year
+166.29%
10 Year
+2154.07%
3 years 2020-03 2021-03 2022-03
Return on Equity (%) 3.96 11.66 19.43
Return on Capital Employed (%) 5.84 14.25 23.92
Return on Assets (%) 2.79 8.25 14.29

Balance Sheet View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 173 194 234 257
Non Curr. Liab. 15 25 23 22
Curr. Liab. 58 54 48 59
Minority Int.
Equity & Liab. 245 273 305 337
Non Curr. Assets 149 163 181 186
Curr. Assets 96 111 124 151
Misc. Exp. not W/O
Total Assets 245 273 305 337

Profit Loss View Details >>

Particulars 4 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 181 211 278 300
Other Income 3 1 1 3
Total Income 184 212 280 303
Total Expenditure -151 -158 -198 -207
PBIDT 33 54 82 96
Interest -4 -2 -2 -3
Depreciation -21 -23 -23 -27
Taxation -1 -7 -14 -17
Exceptional Items -1
PAT 7 21 41 49
Minority Interest
Share Associate
Other Related Items
Consolidated Net Profit 7 21 41 49
Adjusted EPS 3 10 19 22

Cash Flow View Details >>

Particulars 3 years 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 24 37 59
Cash Fr. Inv. -21 -32 -38
Cash Fr. Finan. -1 -5 -17
Net Change 3 1 5
Cash & Cash Eqvt 6 6 11

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 37.46 37.46 37.46 37.46 37.46 37.46 37.46 37.46 37.46
Public 62.54 62.54 62.54 62.54 62.54 62.54 62.54 62.54 62.54
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 01 Dec 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
issued duplicate share certificate(s) on 1st December 2022 of VLL006725 - Muppala Sandhya
Wed, 30 Nov 2022
Announcement under Regulation 30 (LODR)-Credit Rating
M/s Brickwork Ratings India Pvt Ltd has reaffirmed the credit rating for the Bank loan facilities of Rs.57.50 crores.
Tue, 29 Nov 2022
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
ESOP Allotment Committee of the Board of Directors of the Company at their meeting held on29th November 2022 has allotted 5056 equity shares of face value of Rs.2/- .

Technical Scans View Details >>

Mon, 05 Dec 2022
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
High Decrease 1 Month High Decrease 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,386.88 1,035.00 -0.2%
Cipla Ltd. 90,016.94 1,109.60 -0.5%
Divi's Laboratories Ltd. 89,432.38 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. 74,582.06 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. 68,701.75 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. 54,598.02 1,615.60 -0.2%
Abbott India Ltd. 42,923.27 20,207.65 +0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.65 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 35.09 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 29.88 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.99 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 81.83 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 68.50 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 48.68 20,207.65 +0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.69 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-09 4.11 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-09 7.37 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.59 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.48 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 8.96 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-09 15.81 20,207.65 +0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 0.00 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 29.95 20,207.65 +0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,207.65 +0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,035.00 -0.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,109.60 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,355.90 -0.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,374.20 -2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,788.05 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,615.60 -0.2%
Abbott India Ltd. Standalone 2022-03 798.70 20,207.65 +0.7%

FAQ's On Vimta Labs Ltd.

What is Vimta Labs share price?

Can I buy Vimta Labs shares now?

What is the Dividend Yield of Vimta Labs?

What is the Market Cap of Vimta Labs?

What are the key metrics to analyse Vimta Labs?

What is the 52 Week High and Low of Vimta Labs?

What is the trend of Vimta Labs share price?